Cordycepin

Generic Name: Cordycepin

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₁₀H_₁₃N_₅O_₃

CAS Number: 73-03-0

Unique Ingredient Identifier: GZ8VF4M2J8

Background: Cordycepin has been used in trials studying the treatment of Leukemia.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Chemotherapy With Cordycepin Plus Pentostatin in Treating Patients With Refractory Acute Lymphocytic or Chronic Myelogenous Leukemia

Phase 1

Completed

Conditions: Leukemia

Interventions: Drug: Cordycepin
Drug: Deoxycoformycin

First Posted Date: 2004-09-03

Last Posted Date: 2012-06-13

Lead Sponsor: Boston Medical Center

Target Recruit Count: 14

Registration Number: NCT00003005

Locations: 🇺🇸
Johns Hopkins Oncology Center, Baltimore, Maryland, United States
🇺🇸
Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio, United States
🇺🇸
New England Medical Center Hospital, Boston, Massachusetts, United States

and more 10 locations

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy